3//SEC Filing
Shanghai Pharmaceuticals (HK) Investment Ltd 3
Accession 0000899243-20-020208
CIK 0001260990other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:30 PM ET
Size
5.4 KB
Accession
0000899243-20-020208
Insider Transaction Report
Form 3
Holdings
Warrants
Exercise: $2.32Exp: 2026-01-21→ Common Stock (524,658 underlying)- 1,049,317
Common Stock
Footnotes (1)
- [F1]The warrants are currently exercisable into shares of the Issuer's Common Stock except to the extent that the exercise would result in the beneficial ownership of more than 19.99% of the Issuer's outstanding Common Stock.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
IncorporatedHong Kong
Related Parties
1- filerCIK 0001810280
Filing Metadata
- Form type
- 3
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 4:30 PM ET
- Size
- 5.4 KB